Role of CRS plus HIPEC in gastric cancer peritoneal carcinomatosis

E-ISSN： 1096-9098|111|2|248-248

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.2, 2015-02, pp. : 248-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial

Oncology Research and Treatment, Vol. 34, Iss. 3, 2011-02 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 2, 2015-02 ,pp. : 237-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Study of Biweekly Intravenous Paclitaxel plus Intraperitoneal Cisplatin and Paclitaxel for Gastric Cancer with Peritoneal Metastasis

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 7, 2015-06 ,pp. : 840-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunotherapy of Peritoneal Carcinomatosis with Catumaxomab

Oncology Research and Treatment, Vol. 34, Iss. 3, 2011-02 ,pp. : 86-87

Karger

Access to resources Recommend Favorite